NDMAC opposes recommended label comprehension trials to support switches in Canada.
This article was originally published in The Tan Sheet
Executive Summary
OTC SWITCH MANDATORY LABEL COMPREHENSION STUDIES "PREMATURE" IN CANADA, the Nonprescription Drug Manufacturers Association of Canada said in June 28 comments submitted to the Drugs Directorate. The comments respond to specific points made in a final report on the Rx-to-OTC switch process in Canada, prepared for the Bureau of Pharmaceutical Assessment by Panacea Consulting ("The Tan Sheet" May 27, p. 13).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning